Bammental, Germany

Jürgen Kleinschmidt


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jürgen Kleinschmidt: Innovator in AAV Technology

Introduction

Jürgen Kleinschmidt is a notable inventor based in Bammental, Germany. He has made significant contributions to the field of gene therapy, particularly through his work on adeno-associated virus (AAV) technology. With a total of three patents to his name, Kleinschmidt's innovations are paving the way for advancements in medical treatments.

Latest Patents

Kleinschmidt's latest patents include groundbreaking inventions such as modified AAV capsid polypeptides. This invention focuses on providing a polynucleotide encoding an AAV capsid polypeptide that includes an inserted peptide. It also encompasses a vector containing this polynucleotide, along with a host cell that comprises the polynucleotide or vector. Additionally, the invention details a method for manufacturing the capsid polypeptide and includes an antibody that specifically binds to the polypeptide. This innovation has potential applications in developing medicaments for treating vascular diseases.

Another significant patent involves AAV DNA that contains helper virus sequences necessary for developing AAV viral particles. This invention outlines a system that utilizes such DNA and its various applications in the field.

Career Highlights

Throughout his career, Jürgen Kleinschmidt has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum). His work at these organizations has allowed him to focus on innovative research and development in gene therapy.

Collaborations

Kleinschmidt has collaborated with notable colleagues such as Oliver Mueller and Hugo Katus. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jürgen Kleinschmidt's contributions to AAV technology and gene therapy are significant. His innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in medical treatments and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…